AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
AGE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.48%160.690.7%$1221.58m
PFEPfizer Inc. 1.17%37.610.9%$1016.38m
MRKMerck & Co., Inc. 0.35%76.670.7%$965.72m
ABBVAbbVie, Inc. 0.94%106.901.9%$828.02m
BMYBristol-Myers Squibb Co. 1.00%64.451.0%$731.74m
LLYEli Lilly & Co. 1.65%186.011.1%$577.53m
AZNAstraZeneca Plc 1.99%50.831.2%$442.51m
GSKGlaxoSmithKline Plc 4.26%37.670.2%$213.98m
RPRXRoyalty Pharma Plc -1.12%41.650.2%$157.73m
NVSNovartis AG 0.52%87.200.2%$153.46m
VTRSViatris, Inc. 0.53%13.280.0%$128.16m
RGENRepligen Corp. 4.03%213.576.8%$89.09m
CVACCureVac NV 1.40%104.050.0%$87.46m
SNYSanofi 0.90%50.690.2%$60.91m
ATNF180 Life Sciences Corp. -4.02%10.040.0%$60.80m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR, and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.